Stomach carcinogenesis progresses stepwise from normal mucosa/ superficial gastritis, atrophic gastritis (GA) to gastric cancer (GC). Host factors independent of or combined with Helicobacter pylori infection may modulate the carcinogenesis process. In this two-stage study, we selected 24 putative functional tag singlenucleotide polymorphisms (tagSNPs) for six H.pylori-related host genes, MUC1, toll-like receptor 4 (TLR4), protein tyrosine phosphatase, non-receptor type 11 (PTPN11), IL-1B, PGC and PGA3-5, and analyzed their influence and interaction with H.pylori on the GA and GC risks. Using high-throughput genotyping, the 24 tagSNPs were preliminarily assessed in a screening population of 552 controls, 254 GA and 236 GC subjects; subsequently, five candidate tagSNPs for gastric diseases risk in the TLR4, PGC and PTPN11 genes were re-evaluated in a larger population of 1276 controls, 907GA and 714 GC subjects. We observed that PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and/or GC. Moreover, rs4711690 and rs12229892 and H.pylori demonstrated significant interaction effects on GA risk. In gastric cancerous specimens, we observed significantly higher messenger RNA level in the subjects carrying the PGC rs6458238 GA genotype than that in subjects with the common GG genotype. These findings indicated that genetic variations of two crucial H.pylori-related host genes, H.pylori's mucosal effecter PGC gene and H.pylori's cellular messenger PTPN11 gene, either dependent or independent of interaction with H.pylori, were associated with the risks of GC and/or GA that precede carcinoma. Functional studies and further independent large-scale studies especially in other ethnic populations are still needed to confirm our results.
Introduction
Gastric cancer (GC) is one of the most common cancers worldwide. It is characterized by marked genetic heterogeneity, phenotypic complexity and ethnic diversity (1) . It is widely accepted that the carcinogenesis process of GC progresses stepwise from normal stomach, inflammation and precancerous conditions to carcinoma, as described by Correa's cascade (2) . In this cascade, host genetic and environmental factors interact to modulate the transition from one step to the next (3) . Therefore, to understand the carcinogenesis process, it is necessary to identify the host genetic components that play crucial roles in each transitional step, namely, normal mucosa/superficial gastritis (NOR/GS)→atrophic gastritis (GA)→carcinoma transition. Such an understanding may help identify individuals at high risk of developing GC so that early intervention may be taken to help prevent its development.
Helicobacter pylori is the single most important etiological agent in the pathogenesis of GC (1, 4, 5) . At least three steps are required for H.pylori pathogenesis after the bacteria enters the stomach: (i) establishing successful colonization, (ii) evading the host's immune surveillance and (iii) invading into the gastric mucosa (6) . It is becoming increasingly clear that several specific host genes are involved in response to H.pylori colonization, immune escape and mucosal injury in the stomach.
For example, as an inhibitor of H.pylori colonization, epithelial cell mucin1 encoded by MUC1 can block the adhesion of H.pylori blood group antigen-binding adhesin (BabA) and sialic acid-binding adhesin (SabA) to the gastric mucosa, thus limiting H.pylori infection (7) . Another example, as crucial messengers of the gastric epithelial cell signaling response to H.pylori virulence factors, toll-like receptor 4 (TLR4) and src homology 2 domain-containing protein tyrosine phosphatase-2 encoded by TLR4 and protein tyrosine phosphatase, non-receptor type 11 (PTPN11) interact with the virulence lipopolysaccharide and cytotoxin-associated antigen factors, respectively. This interaction activates the corresponding nuclear factor-κB and mitogen-activated protein kinase signal pathways, greatly promoting the production of proinflammatory factors, such as interleukin-1β (IL-1β), IL-8 cytokines and chemokines, or inducing aberrant apoptosis and proliferation (8, 9) . In addition, the serum levels of the major functional proteins in the stomach, pepsinogen (PG) I and II encoded by PGA3-5 and PGC, respectively, correlate well with the functional and morphologic status of the gastric mucosa and rapidly reflect the 'activity' of the H.pylori infection in the stomach (10) (11) (12) .
Recently, genetic and biologic evidence highlighted the important roles of H.pylori-related genetic variations in modulating the H.pylori pathogenicity, thus influencing the host's susceptibility to cancer. A classic example of this paradigm is the study of a Caucasian population. El-Omar et al. (13) identified two promoter polymorphisms (rs16944 and rs1143627) in the IL-1B gene that were in strong linkage disequilibrium and were shown to be associated with an increased risk of both hypochlorhydria induced by H.pylori and GC.
Based on these studies, we hypothesized that certain novel polymorphisms in the H.pylori-related genes described previously may participate in NOR/GS→GA→GC development and contribute to higher susceptibility to cancer for some individuals than the others. In this study, we selected the six H.pylori-related host genes mentioned previously as candidate genes, namely, MUC1, TLR4, PTPN11, IL-1B, PGC and PGA3-5, and screened for putatively functional tag single-nucleotide polymorphisms (tagSNPs). Then, we conducted a two-stage case-control study comprising of a discovery and a validation stages to analyze the genetic effect of H.pylori-related host factors and their interactions with H.pylori on the susceptibilities to GA and GC.
Materials and methods

Participants and study design
This project was approved by the human ethics review committee of the China Medical University. Written informed consent was obtained from each participant. All the subjects in this study were unrelated Chinese Han ethnic inhabiting in northern China, who were recruited from a health check program for GC screening or hospitals in Zhuanghe and Shenyang of Liaoning Province, China between 2002 and 2011. Those who had a history of other malignant neoplasms were excluded. For the candidate-gene association study, Abbreviations: CIs, confidence intervals; CON, control; GA, atrophic gastritis; GC, gastric cancer; GWAS, genome-wide association study; HWE, HardyWeinberg Equilibrium; IL, interleukin; MAF, minor allele frequency; mRNA, messenger RNA; NOR/GS, normal mucosa/superficial gastritis; ORs, odds ratios; PTPN11,protein tyrosine phosphatase, non-receptor type 11; tagSNPs, tag single-nucleotide polymorphisms; TLR4, toll-like receptor 4. three groups of subjects were retrospectively selected from those participants based on their baseline diagnosis: (i) control (CON) group comprised of individuals with normal stomach and subjects with slight or moderate GS without atrophic or intestinal metaplasia lesions; (ii) GA group with or without intestinal metaplasia and (iii) GC group. Exclusion of the CON group included subjects with gastric erosion, peptic ulcer diseases, gastric polyp, adenomas and diseases related to or causing predisposition to cancer.
We adopted a two-stage strategy for this candidate-gene association study ( Figure 1 ). As an exploratory evaluation of selected candidate tagSNPs for disease risk, we carried out the first-stage study in September 2010 in a screening population of 552 CON, 254 GA and 236 GC who were recruited between 2002 and 2004. In October 2011, only those who showed some hints of association were tested in the second-stage study in a validated population of 724 CON, 653 GA and 478 GC who were recruited between 2002 and 2011. Finally, a total of 2897 subjects from both stages, consisted of 1276 CON, 907 GA and 714 GC subjects, were jointly analyzed to validate the association. The characteristics of the study population in this two-stage study were presented in Supplementary Table 1, available at Carcinogenesis Online. In addition, for the messenger RNA (mRNA) expression study, 25 gastric cancerous specimens and 47 non-cancerous specimens were obtained from 47 patients who underwent gastrectomy at the First Affiliated Hospital of China Medical University between 2009 and 2011. Of those individuals, 20 (42.55%) were women and 27 (57.45%) were men, with age ranging from 32 to 76 years (median 59 years). The gastric tissues were excised and immediately frozen in liquid nitrogen and stored at −80°C within 1 h.
Data collection and gastric disease diagnosis
Each participant was interviewed face-to-face by trained interviewers using a standard questionnaire. The gastroscopy examination was performed by experienced endoscopists. Four biopsy specimens were obtained from the body, angulus, antrum and site of the lesion. The stained slides were evaluated independently by two gastrointestinal pathologists. Each patient was assigned a global diagnosis based on the most severe lesion among the four biopsy specimens. Histopathological findings were assessed according to the Consensus on Chronic Gastritis formulated at the National Symposium in combination with the updated Sydney System and the World Health Organization criteria (14) (15) (16) . Meanwhile, 5 ml of fasting blood was collected from each patient for DNA isolation and measurement for serum H.pylori immunoglobulin G. Data including the sex, age, history of illness, native origin, status of smoking, drinking and H.pylori infection and pathological diagnosis were coded in a specific databank. Second, we used the FastSNP search to prioritize the 42 tagSNPs for genotyping based on their predicted functional effects (17, 18) . For example, the following considerations were taken into account as potentially functional effects: causing amino acid substitution, altering splicing or transcription factor-binding motif, intronic enhancer or other functional effects. Accordingly, 24 tagSNPs with predicted functional effects were chosen for genotyping. The common SNPs captured using the selected tagSNPs in the six candidate genes were presented in Supplementary Helicobacter pylori immunoglobulin G antibody assay Serum levels of H.pylori immunoglobulin G antibody were measured using a specific commercial enzyme-linked immunosorbent assay kit (BIOHIT Plc, Helsinki, Finland). A reading >34 enzyme immune-units was assumed to be H.pylori seropositive. Fig. 1 . Flowchart of the study design.
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Quantitative reverse transcriptase-PCR analysis of PGC and PTPN11 mRNA expression
The total RNA from approximately 50 mg of cancer or non-cancer specimens was isolated using TRIzol reagent (Life Technologies, Carlsbad, CA). About 1.5 µg of isolated total RNA was converted into complementary DNA using Quantscript RT kit (Tiangen Biotech, Beijing, China). The mRNA levels specific for PGC and PTPN11 genes and an internal-control gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were examined using SYBR Premix Ex Taq II (TaKaRa Biotech, Dalian, China) in an Eppendorf Mastercycler Gradient System (Eppendorf AG, Hamburg, Germany) according to the manufacturer's protocol. Melting curve analysis was performed to exclude the presence of non-specific products and primer-dimers. Each reaction was performed in duplicates, and no-template controls were included in each experiment. The primers used for the detection of PGC, PTPN11 and GAPDH mRNA levels were summarized in Supplementary Table 4, available at Carcinogenesis Online.
The relative quantification of gene mRNA expression was calculated using the 2 −ΔΔCt method (19) . The expression levels of PGC and PTPN11 were normalized to those of GAPDH in each sample using the equation: ΔCt (delta Ct) = Ct target −Ct GAPDH . Relative expression levels were derived from ΔCt values as 2 −ΔCt . For patients stratified by polymorphic genotypes, the relative expression levels of the common homogenous genotype carriers were set to a unity, and the relative expression levels of patients with heterogeneous and rare homogenous genotypes were expressed relative to those of the common homogenous genotype carriers, thus deriving normalized 2 −ΔΔCt values.
Statistical analysis
All statistical analysis was performed using the SPSS 16.0 statistical software package (SPSS, Chicago, IL). The Hardy-Weinberg Equilibrium (HWE) in the control subjects and in all the subjects in the discovery stage was evaluated using either the chi-square (χ 2 ) test or Fisher's exact test. Differences of sex, H.pylori status and age between the groups were assessed using either the χ 2 test or the analysis of variance test. The association between each polymorphism and risk of GA and GC was estimated by multivariate logistic regression adjusted by sex, age and H.pylori infection and was expressed as odds ratios (ORs) with 95% confidence intervals (CIs). In the discovery stage, SNPs with P values < 0.10 were considered to be potentially associated with disease risk. In the validation stage, the candidate-associated SNPs identified in the discovery stage were re-evaluated, and P values < 0.05 were considered as statistically significant.
In the validation stage using the larger population, we also used multivariate logistic regression adjusted by sex and age to evaluate whether or not H.pylori modify the genetic effect of potentially associated polymorphisms on disease risk in subpopulations stratified by H.pylori status. Moreover, the interaction between a polymorphism and H.pylori infection was assessed using the likelihood ratio test to compare the fitness of the logistic model that included the main effects of sex, age, H.pylori infection and genotype with a fully parameterized model containing the multiplicative interaction terms of genotype and H.pylori. In addition, the distribution of relative gene expression was tested by the Kolmogorov-Smirnov test, and differences of relative mRNA levels between two groups were tested by the Student's t-test. For the above analyses, P values < 0.05 were considered as statistically significant.
Results
In the discovery stage, 24 tagSNPs for the six candidate genes were genotyped in a total of 1042 subjects. Eleven of the SNPs were excluded from further analysis because they were found to have nonpolymorphic sites (TLR4 rs1927912 and PGC rs13213939), to exhibit MAFs < 1% (MUC1 rs11465207, TLR4 rs2737191, TLR4 rs4986791, PGC rs1317897, PGA3 rs2000738, PGA3 rs12799829 and PGA5 rs2286878) or to deviate from HWE (PGA5 rs4939511 and MUC1 rs4702037) (Supplementary Table 4 , available at Carcinogenesis Online). Therefore, a final set of 13 tagSNPs were included in the subsequent analyses.
Among the 13 tagSNPs, five SNPs in three genes showed potential associations with the overall effect risk of CON→GA, GA→GC or CON→GC development, namely, PGC rs4711690, rs9471643 and rs6458238, PTPN11 rs12229892 and TLR4 rs11536878 (P < 0.10) (Table I) . Thus, these five SNPs were used in the validation study.
In the larger population of 2897 subjects, we re-evaluated the association between the five candidate SNPs and the overall risks for GA and GC development, and the results were presented in Table II . Among the five SNPs, we found that PGC rs4711690 and rs6458238 was associated with the overall risk of GA. Compared with the common homozygous genotype, the CG and CG + GG genotypes in rs4711690 and the GA and GA + AA genotypes in rs6458238 was observed to reduce the overall risk of CON→GA development. However, TLR4 rs11536878, PTPN11 rs12229892 and PGC rs9471643 had no effect on the overall risk of gastric diseases.
To assess whether or not H.pylori modified the genetic effects, we further evaluated the association between the five candidate SNPs and disease risk in subpopulations stratified by H.pylori status. The results were presented in Table III . In subjects without H.pylori infection, two polymorphisms (PGC rs4711690 and PTPN11 rs12229892) were associated with risks of CON→GA and CON→GC development. Compared with the common CC genotype, the CG and CG + GG genotypes of rs4711690 were observed to reduce the risk of CON→GA and CON→GC development. Compared with the common GG genotype, the GA, AA and GA + AA genotypes of rs12229892 were associated with a reduced risk of CON→GA development; in addition, the AA genotype reduced the risk of CON→GC development. In infected subjects, PGC rs6458238 and rs4711690 were associated with the risks of CON→GA and GA→GC development, respectively. Compared with the common homogenous genotype, the GA and GA + AA genotypes in rs6458238 were associated with a reduced CON→GA risk, and the GG genotype in rs4711690 reduced the GA→GC risk. For PTPN11 rs12229892, the AA and GA + AA genotypes were associated with an increased risk of CON→GA development.
Thus, because the stratification analyses suggested potential interactions between the three SNPs-PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892-and H.pylori, we selected these three SNPs for the interaction analysis. The results of the analyses were presented in Table IV . The most significant interactions were observed between the PGC rs4711690 and PTPN11 rs12229892 genotypes and H.pylori infection in the development of the CON→GA step (P = 0.006 and 0.001, respectively). PGC rs6458238 and H.pylori infection tended to have an interacting effect on CON→GA and GA-GC development (P = 0.070 and 0.060, respectively).
To explore the possible biological significance of the polymorphisms, we further evaluated the correlation of three associated SNPs (PGC rs4711690, PGC rs6458238 and PTPN11 rs12229892) and one suspected SNP (PGC rs9471643) with mRNA levels (Table V) . In non-tumor specimens, the PGC mRNA levels were marginally correlated with PGC rs9471643 genotypes (P = 0.073). In tumor specimens, significantly higher PGC mRNA levels were observed in subjects carrying PGC rs6458238 GA genotype compared with the patients with common GG genotype (P = 0.025). The PGC mRNA levels tended to be slightly elevated in the tumor tissues of the subjects carrying rs4711690 CC genotype, although this difference was not significant (P = 0.997). Nevertheless, there was no relation between PTPN11 mRNA expression and PTPN11 rs12229892 genotypes.
Discussion
H.pylori-related host genetic factors independent of or combined with H.pylori infection appear to play an important role in modulating the risk of the development of gastric carcinogenesis (20, 21) . To test this hypothesis, we selected six key H.pylori-related host genes as candidates in this two-stage study. Our findings showed that PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and/or GC. Furthermore, the latter two polymorphisms demonstrated significant interaction effects with H.pylori infection on the risk of GA development. We further found that the PGC mRNA levels were statistically correlated with PGC rs6458238 genotypes in cancer tissues.
Since the first genome-wide association study (GWAS) in Japan was published in 2008 (22) , several GWAS either replicating the findings of the first GWAS in other populations or searching new loci have been performed. To date, several regions such as 1q22, 3q13.31, 5p13.1, 6p21.1, 8q24, 10q23 and 20p13 have been reported to associate with GC risk (23-30) . In this study, six important host genes involved in H.pylori-related host gene SNPs and gastric carcinogenesis The two SNPs highlighted in bold influence the overall risk of CON→GA development (P < 0.05).
Successful colonization at the gastric epithelium is the first step for H.pylori infection. Considering that MUC1 is one crucial inhibitor of H.pylori colonization, two coding polymorphisms (rs11465207 and rs4072037) with predicted effect of splicing regulation of this gene were selected in the discovery stage of this study. Previously, a GWAS in Japan (31) and replication studies in Chinese populations (23, 25) have identified the rs4072037 polymorphism as a genetic marker for GC risk. However, both SNPs were excluded from further analysis in this study because rs11465207 had a MAF < 0.01 and the genotype frequency of rs4072037 departed from HWE. We also noted a significant difference of rs4072037 MAF in this study from those in previous studies (23, 25) , indicating a possible technique error in genotyping of rs4072037 in this study. Thus, we had no evidence to suggest that the selected MUC1 polymorphisms were associated with gastric diseases risk in our study population.
After H.pylori being attached to the gastric mucosa, the outer membrane protein can be recognized by the corresponding host receptor, which mediates the evasion of host immunity. TLR4, a pattern recognition receptor presented in the gastric epithelium, is known to interact with H.pylori virulence lipopolysaccharide, which activates the nuclear factor-κB pathway, and then, induces the production of proinflammatory cytokines (including IL-1β) and chemokines, resulting in extensive inflammation (32) (33) (34) . Gastric carcinoma can develop against the background of chronic active H.pylori gastritis via the epithelial precursor lesions. Studies in western populations have reported associations between two coding polymorphisms of TLR4, rs4986790 (Asp299Gly) and rs4986790 (Thr399Ile), and two promoter polymorphisms of IL-1B (rs16944 and rs1143627) and GA and/ or GC risk (35) (36) (37) . However, these two TLR4 SNPs are not found in Asian populations and studies of the two IL-1B SNPs demonstrated discrepant results in Asian subjects. In this study, we analyzed six predicted functional tagSNPs of TLR4 and four predicted functional tagSNPs of IL-1B (also including a frequently studied SNP rs1143627) in the discovery stage. We only found a possible association of TLR4 rs11536878 with GA risk; however, this association was not confirmed in the validation stage. In addition, we found no evidence to suggest that the IL-1B polymorphisms altered the risk of gastric carcinogenesis. We, therefore, speculate that H.pylori genetic variability and host genetic variations between Western and Asian populations may have a major impact on the observed association between these pathwayrelated genes and gastric diseases susceptibilities. Therefore, it appears today very complementary and necessary to develop other polymorphisms in inflammation/immune regulatory genes such as TLR4 and IL-1B that are relevant to H.pylori infection in Asian populations.
Helicobacter pylori is engaged in multiple cellular signal pathways in the gastric epithelium, endowing the bacteria a variety of functional implications and meanwhile, a higher risk of promoting diseases. PTPN11 encodes src homology 2 domain-containing protein Statistically significant higher gene expression (highlighted in bold) was observed between the GG and GA genotypes of PGC rs6458238 in GC tissues.
tyrosine phosphatase-2, which mediates the interaction between the best-characterized virulence factor, cytotoxin-associated antigen and several host signal transduction pathways (38) . This interaction is critical for cellular malformation, aberrant apoptosis and proliferation, and it possibly leads to atrophy and/or cancer (9, 21, 39) . Previously, several studies in Japanese populations have reported an association between rs2301756 in the intron 3 region of PTPN11 with GA in H.pylori infected subjects (40, 41) . Our two-stage study identified another associated SNP (PTPN11 rs12229892) in the intron 10 region of this gene. We found that the rs12229892 variant A-allele was significantly associated with reduced risks of GA and GC in subjects without H.pylori infection and showed association with an increased GA risk in infected individuals. According to the HapMap Chinese Han Beijing data, PTPN11 rs12229892 is not in linkage equilibrium with rs2301756 (r 2 = 0.11) or other common SNPs nearby (r 2 < 0.80); additionally, this polymorphism is very frequently expressed (47-49% for the minor A-allele) in Chinese and Japanese but rare in Caucasians. It is likely that, in addition to the PTPN11 rs2301756 polymorphism previously discovered in Japanese, PTPN11 rs12229892 may be also implicated in the susceptibility of gastric carcinogenesis in Asian populations. The PG II protein (encoded by PGC gene) is a major differentiation biomarker for gastric mucosa that plays a crucial role in maintaining normal cellular function and structure (42) . As a mucosal effecter for H.pylori, serum PG II levels timely reflect the pathophysiological changes in the gastric mucosa and correlate well with the severity of the inflammation response to H.pylori (12, 43) . Few studies on the association between PGC polymorphisms and the risk of gastric diseases are available, and currently, only a 100 bp insertion/deletion in the intron 7 region of this gene has been reported to influence the risk of GC and gastric ulcer (44, 45) . In this study, we identified two novel SNPs in PGC that were associated with susceptibility to gastric carcinogenesis. One novel SNP rs6458238 A-allele was found to be associated with a reduced GA risk and increased PGC mRNA levels in tumor tissues. This polymorphism is located in the PGC promoter region that is predicted to be a binding site of certain transcription factor such as GATA-4 (http://tfbind.hgc.jp/). Therefore, it is speculated that the G→A allele change at the rs6458238 site may increase the DNA binding ability of certain transcription factor, which possibly trigger an increase in the PGC gene expression of A-allele carriers. Another novel SNP rs4711690 was associated with reduced GA and GC risks, especially in subjects uninfected with H.pylori. This SNP is located in intron 5 and in perfect linkage equilibrium with rs4714509 (intron 5) and rs3804279 (intron 7) of this gene (www.hapmap.org). Although no statistical difference of PGC mRNA levels was observed in different rs4711690 genotypes, the possible influence of rs4711690 itself or its linked SNPs on the splicing pattern of PGC gene or transcription efficiency should not be overlooked in future study because the three SNPs are close to exon/intron junctions.
The PG I protein (encoded by the PGA3-5 gene cluster) is another major H.pylori mucosal effecter for which the associations of its genetic variants with gastric carcinogenesis susceptibility have not yet been investigated. In this study, five regulatory polymorphisms located in the 5ʹ upstream and 3ʹ downstream regions of PGA3-5 were examined; however, three of these SNPs (rs2000738, rs12799829 and rs2286878) were excluded from further analysis because their MAFs were <0.01 and one (rs4939511) deviated from HWE. We found no evidence to suggest that the selected PGA3-5 polymorphisms were associated with disease risk in this study population. We observed small differences in the genotype frequencies of these polymorphisms between our data and the HapMap data (www.hapmap.org). This discrepancy might mainly be due to the differences in population structure and genetic diversity between two data sets.
After clarifying the overall effects of the H.pylori-related genetic polymorphisms on diseases risk, we used a larger population in the validation stage to further examine whether these associations were modified by H.pylori infection. Gastric infection with H.pylori was found to be an important effect modifier on the association of the polymorphisms with diseases risk. We observed that the associations of PGC rs4711690 and PTPN11 rs12229892 with reduced risks of GA and GC development were more significant in uninfected subjects, whereas the association of PGC rs6458238 with a reduced GA risk was more evident in infected individuals. Moreover, in the presence of H.pylori infection, PGC rs471160 showed no statistical association with GA risk, and rs12229892 demonstrated an association with an increased GA risk. The above-mentioned findings suggested that the protective effects of PGC rs4711690 and PTPN11 rs12229892 may be counteracted by a causative effect of H.pylori. To investigate how these polymorphisms might interact with H.pylori, we raised the hypothesis that in the presence of H.pylori infection, certain components, modulins or virulence factors of these bacteria might induce a complex network that could partly modify or absolutely shift the functional pattern of the corresponding polymorphic sites in the pathogenesis of cancer or precancerous lesions.
The most statistically significant interactions between the polymorphisms and H.pylori were observed in the risk for GA, but not for GC. Previous studies have shown that H.pylori is a major force that drives the precancerous process because it plays a causative role in persistent inflammation/immune reaction and acid inhibition in the early phases (from NOR/GS→GA); however, the mechanism by which the infection induces cancer is mostly unknown (46) (47) (48) . It has been postulated that at the late phase (GA→GC), in addition to the potential hazards associated with H.pylori infection and atrophy, many other factors may also influence the development of cancer (48) . Nevertheless, our findings suggested that variant genotypes of PGC rs4711690 and PTPN11 rs12229892 carriers who harbor H.pylori may be more susceptible to the cancer precursors. Eradication of the H.pylori infection at the very early phase is considered to be the action of choice to prevent or delay the development of cancer, provided that the presence of neoplastic or preneoplastic lesions is excluded before the treatment (49) .
Several limitations should also be noted. First, we only focused on interactions between genotypes and one major risk factor H.pylori infection, and thus, other potential risk factors such as status of smoking and drinking were not analyzed in this study. Second, we did not employ a stringent multiple testing for the preliminary analyses of the 13 putatively functional tagSNPs in the discovery stage. We only considered the results of the discovery stage as an exploration. Through the candidate approach of the discovery stage, the possible associated SNPs were screened; subsequently, those SNPs were re-evaluated in the validated stage. Such a two-step designed study may allow an internal control of reproducibility of results, which may be partially helpful to restrain publications that turn out to be irreproducible externally. Moreover, intensive analyses on genotype-H.pylori interaction and gene expression may provide evidence on the role of associated SNPs. Third, due to the restricted number of study subjects, we did not have sufficient statistical power especially for the rare polymorphisms. However, when we calculated statistical powers for the three associated common polymorphisms (i.e. rs4711690, rs6458238 and rs12229892) using a power calculator specific for two-stage association studies (CaTS tool: www.sph.umich.edu/csg/abecasis/CaTS), we found that the statistical power ranged from 85% to 100% for GA risk and from 72% to 97% for GC risk. The statistical powers were presented in the Supplementary Table 6 , available at Carcinogenesis Online, in detail.
In summary, this two-stage study identified two novel SNPs in the H.pylori mucosal effecter PGC gene and one SNP in the H.pylori messenger PTPN11 gene associated with GA and/or GC risk. We found that PGC rs6458238 was specifically associated with the risk of GA, and PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and GC. Moreover, the latter two polymorphisms showed significantly statistical interaction effects with H.pylori on the risk of GA development. We also found that PGC mRNA level was statistically altered by PGC rs6458238 genotypes in GC tissues. These findings highlighted that H.pylori-related host variations may be implicated in the susceptibility to gastric carcinoma. Functional studies and further independent large-scale studies especially in other ethnic populations are still needed to confirm our results.
